“We selected the Purexa NAEX membrane chromatography products for our initial expansion into manufacturing-grade offerings due to their broad applicability,” said Jin Zhou, Director of Purilogics.

Nutcracker Therapeutics is driving down costs, accelerating speed of processing and improving scalability with an end-to-end, GMP-grade production process. Healthcare is on the cusp of a ...

Pluri, Inc. ('Pluri”, the 'Company”, 'we” or 'us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its ...

MINNEAPOLIS--(BUSINESS WIRE)--Purilogics, a Donaldson Life Sciences business specializing in biopharmaceutical membrane chromatography development, today announced the availability of its first ...